Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-02-10 @ 9:05 AM
Study NCT ID:
NCT01150903
Status:
COMPLETED
Last Update Posted:
2021-07-19
First Post:
2010-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A1481287
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None